Company profile
Vensica Medical company profile
Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%). Using Vensica’s device, the drug will be instilled in a quick, pain-free procedure subsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates.
Business identity
- Website
- http://vensica.com/
- Contact email
- [email protected]
- Phone number
- +119179638694
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Founded
- 2014-08-01
Headquarters
- Headquarters
- Misgav Dov, Central District, Israel
- Postal code
- 2017400
- Country code
- IL
- Continent
- Asia